Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma

NCT01195922 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

37

Enrollment

NIH

Sponsor class

Conditions

Mouth Neoplasms
Head and Neck Neoplasms
Tongue Neoplasms
Carcinoma, Squamous Cell

Interventions

DRUG: Sirolimus

Sponsor

National Institute of Dental and Craniofacial Research (NIDCR)